{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-23-023719","form_type":"8-K","ticker":"AMS","cik":"0000744825","company_name":"AMERICAN SHARED HOSPITAL SERVICES","filed_at":"2023-08-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:36.587096+00:00","generated_at":"2026-06-11T13:23:29.568315+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"American Shared Hospital Services Q2 net loss $0.02/share; revenue up 10.6% to $5.6M; announces 3rd Gamma Knife order","bullets":["Net loss of $111,000 ($0.02 diluted EPS) vs net income of $497,000 ($0.08) in Q2 2022.","Revenue increased 10.6% to $5.57M; gross margin 45.2% vs 41.5% a year ago.","Operating loss of $325,000 vs operating income of $793,000; reflects $578K impairment reserve from two non-renewed GK agreements.","Announced third Gamma Knife Esprit order for 2023; international center installations progressing (Mexico/LINAC, Ecuador/ICON, Peru/Esprit).","Cash grew to $13.8M; adjusted EBITDA $1.94M vs $2.13M in Q2 2022."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-23-023719","json":"https://secwatch.observer/filing/0001437749-23-023719.json","markdown":"https://secwatch.observer/filing/0001437749-23-023719.md","text":"https://secwatch.observer/filing/0001437749-23-023719.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/744825/000143774923023719/0001437749-23-023719-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/744825/000143774923023719/asha20230814_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-11T13:23:29.568315+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4ca1ba8b6d9f038d83b06520c6c0c5c5ab7e879b","claim":"AMERICAN SHARED HOSPITAL SERVICES reported second quarter ended June 30, 2023 results: revenue $5,568,000.","evidence_excerpt":"systems and services, today announced financial results for the second quarter ended June 30, 2023. Second Quarter 2023 Highlights ● Total revenue in the second quarter was $5,568,000, an increase of 10.6% from the comparable period in 2022. Total proton therapy revenue increased 10.3% period-over-period; fractions increased 3.5%. Gamma Knife revenue increased","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/744825/000143774923023719/0001437749-23-023719-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"second quarter ended June 30, 2023"},{"label":"Revenue","value":"$5,568,000"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}